Bill Gates-Backed Ginkgo Bioworks Going Public Via $15 Billion SPAC

Ginkgo Bioworks will make its market debut by merging with Soaring Eagle Acquisition Corp., the blank-check company led by former MGM CEO Harry Sloan. The SPAC has attracted institutional investors including Cathie Wood of Ark Invest and values the biotech company at $15 billion, triple its last private valuation. The...